McGlynn Margaret G (CIK 0001215126)

Latest company ownership

Shares held
74,872
Last filed at
Jun 6, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q2 2025Q4
Shares held
4,462
Last filed at
May 3, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 4, 2024 Mar 6, 2024 AMICUS THERAPEUTICS, INC. Director Sell 25.0 -15,000 -11.23% ✓ $200.2K
Jan 13, 2023 Jan 17, 2023 AMICUS THERAPEUTICS, INC. Director Sell 15.0 -15,000 -22.83% ✓ $195.4K
May 2, 2022 May 4, 2022 AMICUS THERAPEUTICS, INC. Director Sell 10.0 -15,000 -28.28% ✓ $104.9K
Apr 8, 2022 Apr 12, 2022 VERTEX PHARMACEUTICALS INC / MA Director Sell 5.0 -5,000 -81.98% ✓ $1.4M
Mar 31, 2022 Apr 4, 2022 VERTEX PHARMACEUTICALS INC / MA Director Sell 5.0 -5,000 -81.98% ✓ $1.3M
Jan 28, 2022 Feb 1, 2022 VERTEX PHARMACEUTICALS INC / MA Director Sell 5.0 -5,000 -81.98% ✓ $1.2M
May 3, 2021 May 5, 2021 AMICUS THERAPEUTICS, INC. Director Sell 10.0 -10,000 -26.37% ✓ $102.7K
Apr 17, 2020 Apr 20, 2020 AMICUS THERAPEUTICS, INC. Director Sell 10.0 -10,000 -31.19% ✓ $110K
Jan 9, 2020 Jan 10, 2020 AMICUS THERAPEUTICS, INC. Director Sell 10.0 -20,000 -47.55% ✓ $200K
Oct 22, 2019 Oct 24, 2019 VERTEX PHARMACEUTICALS INC / MA Director Sell 5.0 -20,000 -82.90% ✓ $3.8M
Aug 13, 2019 Aug 15, 2019 VERTEX PHARMACEUTICALS INC / MA Director Sell 5.0 -10,000 -70.80% ✓ $1.9M
May 16, 2018 May 18, 2018 AMICUS THERAPEUTICS, INC. Director Sell 10.0 -10,000 -38.74% ✓ $160K